AstraZeneca Pharma India Limited has informed the Exchange regarding 'Notice of 46th Annual General Meeting '.
ASTRAZEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
AstraZeneca Pharma India has announced its 46th AGM, scheduled for Thursday, August 14, 2025, at 3:00 PM (IST) to be held through video conferencing. Key items on the agenda include adoption of FY25 audited financial statements, declaration of a dividend of ₹32 per equity share for FY 2024-25 (record date: July 18, 2025), and re-appointment of Ms. Hooi Bien Chuah as Director (retiring by rotation). Shareholders will also vote on the appointment of Mr. Praveen Rao Akkinepally as Managing Director for 3 years effective July 1, 2025, with an annual salary of about ₹98.4 lakh, personal pay of about ₹1.48 crore, leased housing up to ₹6 lakh/month, and variable bonus linked to performance. Additionally, M/s. Makarand M. Joshi & Co. is proposed as secretarial auditor for 5 years (FY26–FY30) and M/s. Rao, Murthy & Associates as cost auditor for FY26 at ₹1 lakh remuneration. Remote e-voting opens August 10 and closes August 13, 2025.
The ₹32 dividend per share is a positive return for shareholders, with the record date set at July 18, 2025. The MD appointment and overall leadership continuity should reassure investors, while the disclosed executive pay package (roughly ₹2.5 crore+ fixed pay plus benefits) is the first concrete look at new management compensation.